LSU AI platform used to create COVID-19 treatment

LSU researchers and drug company Skymount Medical are beginning studies on COVID-19 patients involving a combination of medicines, known as SM-19, that have shown to reduce viral load in initial tests…

Already a subscriber? Sign in.

We are glad you enjoy reading Business Report.

Continue reading this story and get ACCESS to all our content from any device with a subscription now.

  • Get access to more than a decade of story archives.
  • Get access to our searchable data center of TOP LISTS.
  • Get exclusive content only available to INSIDERS.